Creating Class I MHC-Null Pigs Using Guide RNA and the Cas9 Endonuclease

被引:104
作者
Reyes, Luz M. [1 ]
Estrada, Jose L. [1 ]
Wang, Zheng Yu [1 ]
Blosser, Rachel J. [1 ]
Smith, Rashod F. [1 ]
Sidner, Richard A. [1 ]
Paris, Leela L. [1 ]
Blankenship, Ross L. [1 ]
Ray, Caitlin N. [1 ]
Miner, Aaron C. [1 ]
Tector, Matthew [2 ]
Tector, A. Joseph [1 ,3 ]
机构
[1] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA
[2] Indiana Univ Hlth, Indianapolis, IN 46202 USA
[3] Indiana Univ Hlth, Transplant Inst, Indianapolis, IN 46202 USA
基金
美国国家卫生研究院;
关键词
MAJOR HISTOCOMPATIBILITY COMPLEX; T-CELLS; KNOCKOUT MICE; ANTIGEN PRESENTATION; PEPTIDE TRANSPORTER; DEFICIENT MICE; IRON OVERLOAD; BINDING-SITE; HLA-B; MOLECULES;
D O I
10.4049/jimmunol.1402059
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pigs are emerging as important large animal models for biomedical research, and they may represent a source of organs for xenotransplantation. The MHC is pivotal to the function of the immune system in health and disease, and it is particularly important in infection and transplant rejection. Pigs deficient in class I MHC could serve as important reagents to study viral immunity as well as allograft and xenograft rejection. In this study, we report the creation and characterization of class IMHC knockout pigs using the Cas9 nuclease and guide RNAs. Pig fetal fibroblasts were genetically engineered using Cas9 and guide RNAs, and class I MHC 2 cells were then used as nuclear donors for somatic cell nuclear transfer. We produced three piglets devoid of all cell surface class I proteins. Although these animals have reduced levels of CD4(-) CD8(+)T cells in peripheral blood, the pigs appear healthy and are developing normally. These pigs are a promising reagent for immunological research.
引用
收藏
页码:5751 / 5757
页数:7
相关论文
共 56 条
  • [1] An early pseudorabies virus protein down-regulates porcine MHC class I expression by inhibition of transporter associated with antigen processing (TAP)
    Ambagala, APN
    Hinkley, S
    Srikumaran, S
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (01) : 93 - 99
  • [2] The Earliest Knockouts
    Bevan, Michael J.
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 184 (09) : 4585 - 4586
  • [3] STRUCTURE, FUNCTION, AND DIVERSITY OF CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES
    BJORKMAN, PJ
    PARHAM, P
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1990, 59 : 253 - 288
  • [4] THE FOREIGN ANTIGEN-BINDING SITE AND T-CELL RECOGNITION REGIONS OF CLASS-I HISTOCOMPATIBILITY ANTIGENS
    BJORKMAN, PJ
    SAPER, MA
    SAMRAOUI, B
    BENNETT, WS
    STROMINGER, JL
    WILEY, DC
    [J]. NATURE, 1987, 329 (6139) : 512 - 518
  • [5] Genome Engineering with Targetable Nucleases
    Carroll, Dana
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, VOL 83, 2014, 83 : 409 - 439
  • [6] The major histocompatibility complex in swine
    Chardon, P
    Renard, C
    Vaiman, M
    [J]. IMMUNOLOGICAL REVIEWS, 1999, 167 : 179 - 192
  • [7] Multiplex Genome Engineering Using CRISPR/Cas Systems
    Cong, Le
    Ran, F. Ann
    Cox, David
    Lin, Shuailiang
    Barretto, Robert
    Habib, Naomi
    Hsu, Patrick D.
    Wu, Xuebing
    Jiang, Wenyan
    Marraffini, Luciano A.
    Zhang, Feng
    [J]. SCIENCE, 2013, 339 (6121) : 819 - 823
  • [8] Development of CD8α/α and CD8α/β T cells in major histocompatibility complex class I-deficient mice
    Das, G
    Janeway, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (06) : 881 - 884
  • [9] HOMOZYGOUS HUMAN TAP PEPTIDE TRANSPORTER MUTATION IN HLA CLASS-I DEFICIENCY
    DELASALLE, H
    HANAU, D
    FRICKER, D
    URLACHER, A
    KELLY, A
    SALAMERO, J
    POWIS, SH
    DONATO, L
    BAUSINGER, H
    LAFORET, M
    JERAS, M
    SPEHNER, D
    BIEBER, T
    FALKENRODT, A
    CAZENAVE, JP
    TROWSDALE, J
    TONGIO, MM
    [J]. SCIENCE, 1994, 265 (5169) : 237 - 241
  • [10] IRON OVERLOAD IN BETA(2)-MICROGLOBULIN-DEFICIENT MICE
    DESOUSA, M
    REIMAO, R
    LACERDA, R
    HUGO, P
    KAUFMANN, SHE
    PORTO, G
    [J]. IMMUNOLOGY LETTERS, 1994, 39 (02) : 105 - 111